| Product Code: ETC7544309 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India generic pharmaceutical market import shipments demonstrated a steady growth trajectory from 2020 to 2024, with a moderate CAGR of 5.4%. Notably, between 2023 and 2024, the growth rate accelerated to 6.3%, indicating an expanding market momentum and sustained upward trend in imports.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Generic Pharmaceutical Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Generic Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 India Generic Pharmaceutical Market - Industry Life Cycle |
3.4 India Generic Pharmaceutical Market - Porter's Five Forces |
3.5 India Generic Pharmaceutical Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Generic Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Generic Pharmaceutical Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 India Generic Pharmaceutical Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Generic Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Generic Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for affordable healthcare solutions in India |
4.2.2 Growing prevalence of chronic diseases driving the need for generic pharmaceuticals |
4.2.3 Favorable government initiatives to promote generic drug usage |
4.3 Market Restraints |
4.3.1 Regulatory challenges and compliance issues in the generic pharmaceutical sector |
4.3.2 Intense competition leading to pricing pressures |
4.3.3 Concerns regarding the quality and efficacy of generic drugs |
5 India Generic Pharmaceutical Market Trends |
6 India Generic Pharmaceutical Market, By Types |
6.1 India Generic Pharmaceutical Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Generic Pharmaceutical Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Generic Pharmaceutical Market Revenues & Volume, By Simple Generics, 2021- 2031F |
6.1.4 India Generic Pharmaceutical Market Revenues & Volume, By Specialty Generics, 2021- 2031F |
6.1.5 India Generic Pharmaceutical Market Revenues & Volume, By Biosimilars, 2021- 2031F |
6.2 India Generic Pharmaceutical Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Generic Pharmaceutical Market Revenues & Volume, By Central Nervous System Disorders, 2021- 2031F |
6.2.3 India Generic Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.2.4 India Generic Pharmaceutical Market Revenues & Volume, By Hormones & Related Diseases, 2021- 2031F |
6.2.5 India Generic Pharmaceutical Market Revenues & Volume, By Gastrointestinal Diseases, 2021- 2031F |
6.2.6 India Generic Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.7 India Generic Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3 India Generic Pharmaceutical Market, By Product |
6.3.1 Overview and Analysis |
6.3.2 India Generic Pharmaceutical Market Revenues & Volume, By Small Molecule, 2021- 2031F |
6.3.3 India Generic Pharmaceutical Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.4 India Generic Pharmaceutical Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Generic Pharmaceutical Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 India Generic Pharmaceutical Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 India Generic Pharmaceutical Market Revenues & Volume, By Inhalable, 2021- 2031F |
6.4.5 India Generic Pharmaceutical Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Generic Pharmaceutical Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Generic Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.3 India Generic Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.4 India Generic Pharmaceutical Market Revenues & Volume, By Others, 2021- 2031F |
7 India Generic Pharmaceutical Market Import-Export Trade Statistics |
7.1 India Generic Pharmaceutical Market Export to Major Countries |
7.2 India Generic Pharmaceutical Market Imports from Major Countries |
8 India Generic Pharmaceutical Market Key Performance Indicators |
8.1 Percentage growth in the number of prescriptions for generic drugs |
8.2 Average time from product development to market launch for generic pharmaceuticals |
8.3 Percentage increase in RD investment in generic drug development |
8.4 Number of strategic partnerships and collaborations to enhance market presence |
8.5 Adoption rate of generic drugs among healthcare providers and patients |
9 India Generic Pharmaceutical Market - Opportunity Assessment |
9.1 India Generic Pharmaceutical Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Generic Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Generic Pharmaceutical Market Opportunity Assessment, By Product, 2021 & 2031F |
9.4 India Generic Pharmaceutical Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Generic Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Generic Pharmaceutical Market - Competitive Landscape |
10.1 India Generic Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 India Generic Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here